Subscribe To
3 beaten-down dividend stocks you could regret not buying on the dip
Ally Financial is a digital bank that offers a dividend yield above 5% at recent prices. Thermo Fisher Scientific's COVID-19 testing revenue has evapo...
October 30, 2023, 5:57 am
Premier foods £34m breakfast move lauded by the city
Premier Foods PLC has made its entry into the breakfast market with the acquisition of FUEL10K for an ...
October 30, 2023, 5:44 am
Usd/jpy dips on tokyo cpi climb, dollar index finishes flat
The Dollar Index (DXY), a popular gauge of the Greenback’s value against a basket of 6 major currencies, ended flat, at 106.58 (106.60). The US curr...
October 30, 2023, 5:44 am
Versarien on track with turnaround plans
Versarien told shareholders its turnaround continues to make progress with an increasing level of comme...
October 30, 2023, 5:23 am
Intuitive machines stock climbs on lunar mission plan as mcdonald's edges higher ahead of results
Coherus BioSciences stock CHRS, -3.65% rose 17% as the Food and Drug Administration approved its treatm...
October 30, 2023, 5:20 am
Kimco is attractive for income seeking investors
Kimco's stock has lost 18% of its value in the past year, but the company has been raising ...
October 30, 2023, 5:15 am
Vaneck amends spot bitcoin etf application amid increasing number of updated filings
Joining a growing list of asset managers, VanEck has amended its application for a spot Bitcoin (CRYPTO...
October 30, 2023, 5:14 am
Tjul: wait for the next series
Innovator Equity Defined Protection ETF offers 2-year downside protection and modest upside capture for conservative investors. The ETF uses options t...
October 30, 2023, 4:59 am
Gold price trades near its highest level since may on the back of geopolitical risks
Gold price manages to hold above the $2,000 psychological mark on Monday and continues to draw support from the increasing risk of an escalation of ge...
October 30, 2023, 4:44 am
Rainbow rare earths making 'rapid progress' at key projects
Rainbow Rare Earths said rapid progress is being made at its Phalaborwa phosphogypsum project in South ...
October 30, 2023, 4:41 am
Base resources to stop kwale operations at end of 2024
Base Resources has confirmed that mining at its Kwale operations in Kenya will end in December 2024 wit...
October 30, 2023, 4:06 am
Chinese communist party seems to have convinced firms to buy back shares, prop up market
Reuters reports on plans for more listed companies on China to buy back shares: More than 30 Chinese listed companies unveiled share buyback and purch...
October 30, 2023, 3:58 am
U.s. bancorp series a preferred: trading at discount with over 9% yield
U.S. Bancorp's Series A preferred shares are on pace to pay a dividend yield of 9.1% over the next twelve months. The bank's net interest income has d...
October 30, 2023, 3:46 am
Novartis says drug candidate is successful in rare kidney disease trial
Novartis said its experimental drug atrasentan was shown to have a positive effect on kidney function i...
October 30, 2023, 3:42 am
Technical outlook and review
DXY: The DXY chart currently exhibits bullish momentum, suggesting the potential for a bullish continua...
October 30, 2023, 3:42 am
Hsbc launches $3 billion buyback as revenue soars
HSBC Holdings PLC (LSE:HSBA) reported strong growth in revenue and profit in the third quarter alongside plans for a new $3 billion share buy-back. Th...
October 30, 2023, 3:31 am
Cassava sciences: my bullish take on biomarkers and ctad data
Cassava Sciences' stock is highly disputed due to conflicting opinions on the science behind its drug c...
October 30, 2023, 3:30 am
Dht holdings, inc. to announce third quarter 2023 results on monday, november 7, 2023
HAMILTON, BERMUDA, October 30, 2023 - DHT Holdings, Inc. (NYSE: DHT or the “Company”) will release its...
October 30, 2023, 3:29 am
Google: buy this ai-driven company on the post-earnings dip
Alphabet beats revenue and earnings estimates, but cloud revenue disappoints. Alphabet has a significant advantage in AI and has the financial resourc...
October 30, 2023, 3:25 am
Gsk says endometrial cancer drug meets primary goal in late-stage trial
British drugmaker GSK said on Monday its cancer drug Jemperli met the primary goal of overall survival ...
October 30, 2023, 3:16 am